Zobrazeno 1 - 10
of 138
pro vyhledávání: '"Georgic, LM"'
Autor:
Pugsley, TA, Davis, MD, Akunne, HC, MacKenzie, RG, Shih, YH, Damsma, G, Wikstrom, H, Whetzel, SZ, Georgic, LM, Cooke, LW, Demattos, SB, Corbin, AE, Glase, SA, Wise, LD, Dijkstra, D, Heffner, TG
Publikováno v:
Journal of Pharmacology and Experimental Therapeutics, 275(3), 1355-1366. WILLIAMS & WILKINS
The present study determined the biochemical and pharmacological effects of PD 128907 [R-(+)-trans-3,4,4a,10b-tetrahydro-4-propyl-2H,5H-[1]benzopyrano[4,3-6]-1,4-oxazin-9-ol], a dopamine (DA) receptor agonist that shows a preference for the human D3
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=narcis______::db05c72d5eaa108f955f8fdf1b57db75
https://research.rug.nl/en/publications/27f2c731-e4cf-4766-969c-82d5ca5ced44
https://research.rug.nl/en/publications/27f2c731-e4cf-4766-969c-82d5ca5ced44
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Akunne HC; Neuroscience Therapeutics, Parke-Davis Pharmaceutical Research, Division of Warner-Lambert Company, Ann Arbor, USA. hyacinth.akunne@wl.com, Zoski KT, Davis MD, Cooke LW, Meltzer LT, Whetzel SZ, Shih YH, Wustrow DJ, Wise LD, MacKenzie RG, Georgic LM, Heffner TG, Pugsley TA
Publikováno v:
Neuropharmacology [Neuropharmacology] 2000 Apr 27; Vol. 39 (7), pp. 1197-210.
Pharmacological characterization of PD 152255, a novel dimeric benzimidazole dopamine D3 antagonist.
Autor:
Corbin AE; Psychiatric Disorders Therapeutics, Parke-Davis Pharmaceutical Research, Division of Warner-Lambert Company, Ann Arbor, MI 48105, USA., Pugsley TA, Akunne HC, Whetzel SZ, Zoski KT, Georgic LM, Nelson CB, Wright JL, Wise LD, Heffner TG
Publikováno v:
Pharmacology, biochemistry, and behavior [Pharmacol Biochem Behav] 1998 Feb; Vol. 59 (2), pp. 487-93.
Autor:
Whetzel SZ; Psychiatric Disorders, Therapeutics, Parke-Davis Pharmaceutical Research Division, Warner-Lambert Co., Ann Arbor, Michigan 48105, U.S.A., Shih YH, Georgic LM, Akunne HC, Pugsley TA
Publikováno v:
Journal of neurochemistry [J Neurochem] 1997 Dec; Vol. 69 (6), pp. 2363-8.
Autor:
Glase SA; Department of Chemistry, Parke-Davis Pharmaceutical Research, Division of Warner-Lambert Company, Ann Arbor, Michigan 48105, USA., Akunne HC, Georgic LM, Heffner TG, MacKenzie RG, Manley PJ, Pugsley TA, Wise LD
Publikováno v:
Journal of medicinal chemistry [J Med Chem] 1997 Jun 06; Vol. 40 (12), pp. 1771-2.
Autor:
Glaum SR; Department of Physiology, Northwestern University Medical School, Chicago, IL 60611, USA., Miller RJ, Rhim H, Maclean D, Georgic LM, MacKenzie RG, Grundemar L
Publikováno v:
British journal of pharmacology [Br J Pharmacol] 1997 Feb; Vol. 120 (3), pp. 481-7.
Autor:
Wustrow DJ; Department of Chemistry, Parke Davis Pharmaceutical Research, Division of Warner Lambert Company, Ann Arbor, Michigan 48105, USA., Smith WJ 3rd, Corbin AE, Davis MD, Georgic LM, Pugsley TA, Whetzel SZ, Heffner TG, Wise LD
Publikováno v:
Journal of medicinal chemistry [J Med Chem] 1997 Jan 17; Vol. 40 (2), pp. 250-9.
Autor:
Pugsley TA; Department of Therapeutics, Parke-Davis Pharmaceutical Research, Division of Warner-Lambert Co., Ann Arbor, Michigan, USA., Davis MD, Akunne HC, MacKenzie RG, Shih YH, Damsma G, Wikstrom H, Whetzel SZ, Georgic LM, Cooke LW, et. al.
Publikováno v:
The Journal of pharmacology and experimental therapeutics [J Pharmacol Exp Ther] 1995 Dec; Vol. 275 (3), pp. 1355-66.